Effect of Local Infiltration Anesthesia With Ropivacaine on Pain After Primary Total Hip Arthroplasty

Sponsor
St. Olavs Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02359136
Collaborator
(none)
116
1
2
22
5.3

Study Details

Study Description

Brief Summary

Background: The Local infiltration analgesic (LIA) technique has been widely used to reduce opioid requirements and improve the patient's mobilization after total hip arthroplasty (THA). However, the evidence for LIA in THA remains to be clarified.

Purpose: To evaluate whether a single shot LIA in addition to a multimodal analgesic regimen reduces acute postoperative pain and opioid requirements after THA.

Condition or Disease Intervention/Treatment Phase
  • Procedure: local infiltration anesthesia using Ropivacaine and Epinephrine
  • Procedure: local infiltration anesthesia using saline
  • Procedure: Multimodal analgesic regimen
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
116 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Effect of Local Infiltration Anesthesia With Ropivacaine on Pain After Primary Total Hip Arthroplasty
Actual Study Start Date :
Mar 1, 2013
Actual Primary Completion Date :
Mar 1, 2014
Actual Study Completion Date :
Jan 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: LIA placebo

local infiltration anesthesia using saline i addition to multimodal analgesic regimen

Procedure: local infiltration anesthesia using saline
150 ml 0,9% saline: The first 50 ml will be injected in the periacetabular tissue after insertion of the acetabular component. After insertion of the femoral component, 50 ml will be inserted in the gluteus muscles and the proximal part of the iliotibial tract. The last 50 ml will be inserted in the subcutaneous layer.

Procedure: Multimodal analgesic regimen
All patients will be operated under spinal anaesthesia with 2.0-3.0 ml Bupivacaine 0.5 % plain, preferably at the L2/L3 alternatively the L3/L4 vertebral interspace. Propofol infusion will be administrated for sedation if needed. Postoperative morphine will be given as needed intravenously when needed. After transfer to a specialized hip arthroplasty unit with a well-defined and experienced program for multimodal rehabilitation, multimodal oral opioid-sparing analgesia will be given to all patients; NSAIDS and Acetaminophen will be given at regular intervals and Oxycodone as needed.

Experimental: LIA Ropivacaine

local infiltration anesthesia using Ropivacaine and Epinephrine i addition to multimodal analgesic regimen

Procedure: local infiltration anesthesia using Ropivacaine and Epinephrine
150 ml Ropivacaine 2mg/ml + 0,5 ml Epinephrine 1 mg/ml: The first 50 ml will be injected in the periacetabular tissue after insertion of the acetabular component. After insertion of the femoral component, 50 ml will be inserted in the gluteus muscles and the proximal part of the iliotibial tract. The last 50 ml will be inserted in the subcutaneous layer.

Procedure: Multimodal analgesic regimen
All patients will be operated under spinal anaesthesia with 2.0-3.0 ml Bupivacaine 0.5 % plain, preferably at the L2/L3 alternatively the L3/L4 vertebral interspace. Propofol infusion will be administrated for sedation if needed. Postoperative morphine will be given as needed intravenously when needed. After transfer to a specialized hip arthroplasty unit with a well-defined and experienced program for multimodal rehabilitation, multimodal oral opioid-sparing analgesia will be given to all patients; NSAIDS and Acetaminophen will be given at regular intervals and Oxycodone as needed.

Outcome Measures

Primary Outcome Measures

  1. postoperative pain assessed by numeric rating scale [1 day (first postoperative day)]

    assessed by numeric rating scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • all patients receiving total hip arthroplasty in the study period
Exclusion Criteria:
  • contraindications to receive spinal anesthetic, Dexamethasone or Acetaminophen.

  • Patients who received general anaesthetic

  • patients who will get a different operation than standard direct lateral surgery

  • Patients with osteosynthesis to be removed in the same operation

Contacts and Locations

Locations

Site City State Country Postal Code
1 St.Olavs Hospital, Department of Orthopedics Trondheim Norway 7006

Sponsors and Collaborators

  • St. Olavs Hospital

Investigators

  • Principal Investigator: Tina Strømdal Wik, md phd, St. Olavs Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
St. Olavs Hospital
ClinicalTrials.gov Identifier:
NCT02359136
Other Study ID Numbers:
  • 2012/1999
First Posted:
Feb 9, 2015
Last Update Posted:
Mar 31, 2017
Last Verified:
Mar 1, 2017
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by St. Olavs Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 31, 2017